Trial Profile
A Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically Under Maximal Use Conditions for the Treatment of Head Lice Infestation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2020
Price :
$35
*
At a glance
- Drugs Abametapir (Primary)
- Indications Pediculosis
- Focus Adverse reactions
- Sponsors Hatchtech
- 10 Dec 2013 New trial record